Lifestyle???? IMU have advanced VAXINIA, OASIS and Azer-Cel and will start Ph2 clinical trial for PD1-Vaxx this year and just announced further positive clinical trial update for Azer-Cel and HER-Vaxx has completed Ph2 clinical trial with very good result. Their salary and corporate and administration cost is $5-7M when there are companies which spend $2M with only one product which doesn't have the potential of 1 of IMU's IP let alone 5 of them.
Get better and try again.
IMU Price at posting:
4.3¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)